Olmesartán/Amlodipino Normon (Olmesartan Medoxomil, Amlodipine)

Olmesartan medoxyl?, the active ingredient in Olmesartán/Amlodipino Normon, is a angiotensin II receptor blocker presented as a oral tablet for systemic use. It treats hypertension, often in combination with a calcium‑channel blocker, and is intended for adult patients. GNH USA supplies Olmesartán/Amlodipino Normon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartán/Amlodipino Normon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan/amlodipine is used in cardiovascular therapy ‑ the combination targets blood‑pressure regulation.

- Hypertension: provides effective blood‑pressure reduction when monotherapy is insufficient. - Chronic kidney disease with hypertension: helps protect renal function by lowering systemic pressure. - Heart failure with preserved ejection fraction: contributes to afterload reduction and symptom control. - Diabetes‑related hypertension: assists in achieving target blood‑pressure goals in patients with metabolic disease. - High‑risk cardiovascular patients: lowers the risk of stroke and myocardial infarction as part of comprehensive risk management. - Elderly patients with isolated systolic hypertension: offers a smooth titration profile suitable for older adults.

Side effects may occur with any antihypertensive regimen and should be monitored during therapy.

Common Side Effects: - Headache  - Peripheral edema  - Dizziness  - Flushing  - Fatigue  - Nasal congestion

Serious or Rare Side Effects: - Angio‑angulation  - Severe hypotension  - Hepatic enzyme elevation  - Acute kidney injury  - Myocardial infarction  - Life‑threatening arrhythmias  - Stevens  -              

The             ... 

-   t   t  "  " """"  " "" " "" "  "" ... ",